07/04/2023
Advanced Regenerative Pain Management: Beyond Pills
Regenerative therapies are aimed at repairing damage to joint and soft tissue structures such as tendon tears, ligament sprains, cartilage degeneration, and muscle strains. A variety of injection therapies directed at the site of injury have been developed and evaluated for safety and efficacy. These include Prolotherapy, Prolozone therapy, Neural therapy, Peri-neural injections, and Hyaluronic acid joint injections.
Depending on the injury or degenerative condition, one or more of these therapies may be indicated. The main therapies applied at the Natural Family Health Clinic are Prolozone, Peri-neural therapy, and Hyaluronic acid injections due to a long history of effectiveness and a high degree of tolerance to these therapies (they are minimally painful to the patient).
Prolozone is an injectable pain management therapy developed by Dr. Frank Shallenberger, a renowned anti-aging Doctor and “the father” of modern ozone therapy in North America. Prolozone is effective for all forms of musculo-skeletal and joint pain including chronic neck, back, knee, hip, and shoulder pain, plantar fasciitis, carpal tunnel syndrome, and rotator cuff injuries. According to Dr. Shallenberger, because prolozone corrects the underlying pathology of the disorder, there is a 75% chance the chronic pain will be resolved completely. Research supports this conclusion.
Prolozone involves the targeted injection of a homeopathic/procaine/vitamin-mineral healing solution followed by ozone. Ozone is an oxygen gas produced by an ozone generator that effectively oxygenates tissues, both sterilizing them and enhancing the oxygen utilization of the tissue. It is the most highly active form of oxygen in the universe and provides energy to our cells. This oxygenation is very healing as well as neutralizing to the pain in an area. Poor circulation often leads to poor oxygen concentration in and around joints. Ozone increases oxygen levels considerably leading to joint and tissue regeneration. Generally, 3-5 Prolozone treatments are required to completely resolve pain, injuries, and stimulate regeneration of worn-out joints. These occur at a schedule of once every 2 weeks to once a month. This therapy is extremely safe, well supported by over 50 years of research, and most often is well tolerated. It is often administered to patients waiting for joint replacements and can prevent the need for urgent surgery.
Dr. John Lyftogt from New Zealand has developed an elegant, minimally invasive, and extremely effective pain management technique using a simple glucose solution. This technique, coined Peri-neural injection therapy (PIT), employs tiny injections of a 5% Dextrose (glucose) solution just under the skin at specific sites which correspond to nerve impingement sites. Often these sites also correspond to acupuncture points. By bathing the nerves with fluid and energy they can repair and function optimally. And, it has been discovered, that when the nerves are functioning optimally, the joint, muscle, ligament, tendon, bursa, and fascia tissues are also able to heal and regenerate efficiently.
These injections are not deep or painful; often the patient feels only minimal discomfort. Pain relief can be immediate and long lasting. Generally, 4-6 treatments at one per week are required to completely resolve chronic pain, however, every person is unique and the response is therefore variable. Research shows that 80-90% of all pain is responsive to glucose.
How can such as simple technique be so effective? The principal mechanism of action of the 5% Dextrose solution is to block the receptor in the nerve (TRPV-1 or Capsaicin receptor) which is the body’s main regulator of pain and inflammation. Resetting the receptors in the nerves allows for healing to deeper structures (joint cartilage for example). Therefore, not only is this therapy pain relieving but it is also regenerative.
Hyaluronic Acid Knee Injections:
Hyaluronic acid is found naturally in your knee joint to provide cushioning and lubrication. With osteoarthritis, the amount of this fluid can decrease, and the fluid can become thinner. For this reason, doctors may recommend an injection of hyaluronic acid, especially when steroid injections and other therapies do not provide significant relief. For injection purposes, hyaluronic acid is administered weekly for 3-5 weeks and generally provides long-term relief from knee pain. This treatment regimen can be repeated in 6 months if needed.
Hyaluronic acid injections, also known as viscosupplementation, are mostly used to treat osteoarthritis but have been used to treat knees affected by rheumatoid arthritis as well. The benefits appear to last for about five to six months. Different versions of this kind of treatment exist and some require multiple injections over several weeks. Treatment can be repeated after a six-month waiting period.
Beyond just providing extra cushion and lubrication, the injection may also work by:
-Anti-inflammatory mechanisms
-Promote partial joint healing
-Decreasing nerve sensitivity in the joint
-Shock absorber effect
If you are suffering from pain, are tired of taking pain killers, and want to improve the ability of your body to do the things you love without suffering, contact our clinic to find out which therapies are best suited to your personal needs.
You can reach the Natural Family Health Clinic at 250-497-6681 or at www.drtamarabrowne.ca
Prolozone References
1. Cardoso CC, Carvalho JC, Ovando EC, Macedo SB, Dall'Aglio R, Ferreira LR. Action of ozonized water in preclinical inflammatory models. Pharmacol Res. 2000;42:51-54.
2. Lopes de Jesus CC, Dos Santos FC, de Jesus LMOB, Monteiro I, Sant’Ana MSSC, Trevisani VFM. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study. PLoS One. 2017;12:e0179185.
3. Cardelli R, de Santis F, Dall'Olio M, Leonardi M. Osteoarthritis of the hip treated by intra-articular infiltration of oxygen-ozone and hyaluronic acid (Hyalubrix®). Preliminary results. Int J Ozone Ther. 2008;7:66-69.
4. Bocci V, Larini A, Micheli V. Restoration of normoxia by ozone therapy may control neoplastic growth: a review and a working hypothesis. J Altern Complement Med. 2005;11:257-265.
5. Inal M, Dokumacioglu A, Özcelik E, Ucar O. The effects of ozone therapy and coenzyme Q10 combination on oxidative stress markers in healthy subjects. Ir J Med Sci. 2011;180:703-707.
6. Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007;2007:26785.
7. Mancuso C, Capone C, Ranieri SC, et al. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res. 2008;86:2235-2249.
8. Barone E, Trombino S, Cassano R, et al. Characterization of the Sdenitrosylating activity of bilirubin. J Cell Mol Med. 2009;13:2365- 2375.
9. Dattilo S, Mancuso C, Koverech G, et al. Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing. 2015;12:20.
10. Mancuso C, Pistritto G, Tringali G, Grossman A, Preziosi P, Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes.Brain Res Mol Brain Res. 1997;45:294-300.
11. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004;13:3-11.
12. Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425-435.
13. Re L, Mawsouf MN, Menendez S, Leon OS, Sanchez GM, Hernandez F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39:17-26.
14. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci. 1999;56:270-279.
15. Lim Y, Phung AD, Corbacho AM, et al. Modulation of cutaneous wound healing by ozone: differences between young and aged mice. Toxicol Lett. 2006;160:127-134.
16. Rahimi-Movaghar V, Eslami V. The major efficient mechanisms of ozone therapy are obtained in intradiscal procedures. Pain Physician. 2012;15:E1007-E1008.
17. Bocci V, Zanardi I, Travagli V. Has oxygen-ozonetherapy a future in medicine.J Exp Integr Med. 2011;1:5-11.
18. Daif E.Role of intra-articular ozone gas injection in the management of internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:e10-e14.
19. Jordan J, Konstantinou K, O'Dowd J. Herniated lumbar disc. BMJ Clin Evid. 2009;2009:1118.
20. Bellomo G, Mirabelli F, Salis A, et al. Oxidative stress-induced plasma membrane blebbing and cytoskeletal alterations in normal and cancer cells. Ann N Y Acad Sci. 1988;551:128-130.
21. Iliakis E, Valadakis V, Vynios DH, Tsiganos CP, Agapitos E. Rationalization of the activity of medical ozone on intervertebral disc a histological and biochemical study. Riv Neuroradiol. 2001;14:S23- 30.
22. Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR Am J Neuroradiol. 2003;24:996-1000.
23. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993;12:121-126.
24. Matsui H, Terahata N, Tsuji H, Hirano N, Naruse Y. Familial predisposition and clustering for juvenile lumbar disc herniation. Spine (Phila Pa 1976). 1992;17:1323-1328.
25. Leonardi M. Disc puncture under fluoroscopic guidance. Riv Ital Ossigeno-Ozonoterapia. 2002;1:73-78.
26. Terry GC, Chopp TM. Functional anatomy of the shoulder. J Athl Train. 2000;35:248-255.
27. Benvenuti P. Oxygen-ozone treatment of the knee, shoulder and hip: A personal experience. Rivista Italiana di Ossigeno-Ozonoterapia. 2006;5:135-144.
28. Neviaser AS, Neviaser RJ. Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg. 2011;19:536-542.
29. Hirji Z, Hunjun JS, Choudur HN. Imaging of the bursae. J Clin Imaging Sci. 2011;1:22.
30. Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85:49-56.
31. Riva Sanseverino E. Intensive medical physical treatment of osteoporosis with the AID of oxygen-ozone therapy. Europa Medico Physica. 1989;25:163-170.
32. Ibrahim I, Khan WS, Goddard N, Smitham P. Carpal tunnel syndrome: a review of the recent literature. Open Orthop J. 2012;6:69- 76.
33. Katz JN, Simmons BP. Clinical practice. Carpal tunnel syndrome. N Engl J Med. 2002;346:1807-1812. Seyam et al. / Med Gas Res 110 Medical Gas Research ¦ September ¦ Volume 8 ¦ Issue 3 www.medgasres.com
34. Bocci V.Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents.1996;10:31-53.
35. Simonetti L, Raffi L, Cenni P, Agati R, Leonardi M. Pharmacological mechanisms underlying oxygen-ozone therapy for herniated disc. Rivista Italiana Di Ossigeno. 2003;16:S201-204.
36. Zambello A, Fumagalli L, Fara B, Bianchi MM. Oxygen-ozone treatment of carpal tunnel syndrome. Retrospective study and literature review of conservative and surgical techniques. Int J Ozone Ther. 2008;7:45-48.
37. Volk AG, Vangsness CT Jr. An anatomic study of the supraspinatus muscle and tendon. Clin Orthop Relat Res. 2001:280-285.
38. Moretti M. Effect of treatment with O2 -O3 and hyaluronic acid in partial tear of the supraspinatus tendon. Int J Ozone Ther. 2012;11:98-100.
39. Donnally IC, Dulebohn SC. Lumbar Spondylolysis and Spondylolisthesis. Treasure Island: StatPearls. 2018.
40. Bonetti M, Fontana A, Albertini F. CT-guided oxygen-ozone treatment for first degree spondylolisthesis and spondylolysis. Acta Neurochir Suppl. 2005;92:87-92.
41. R. Jinkins J. The pathoanatomic basis of somatic, autonomic and neurogenic syndromes originating in the lumbosacral spine. Rivista di Neuroradiologia. 1995;8:S35-51.
42. Bocci V, Luzzi E, Corradeschi F, et al. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J Biol Regul Homeost Agents. 1993;7:133-138.
43. Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses. 1996;46:150-154.
44. Bocci V, Luzzi E, Corradeschi F, Silvestri S. Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment. J Biol Regul Homeost Agents. 1994;8:108-112.
45. Muto M, Andreula C, Leonardi M. Treatment of herniated lumbar disc by intradiscal and intraforaminal oxygen-ozone (O2 -O3 ) injection. J Neuroradiol. 2004;31:183-189.
46. Lu W, Li YH, He XF. Treatment of large lumbar disc herniation with percutaneous ozone injection via the posterior-lateral route and inner margin of the facet joint. World J Radiol. 2010;2:109-112.
47. Saal JA, Saal JS, Herzog RJ. The natural history of lumbar intervertebral disc extrusions treated nonoperatively. Spine (Phila Pa 1976). 1990;15:683-686.
48. Alexandre A, Coro L, Azuelos A, et al. Intradiscal injection of oxygen-ozone gas mixture for the treatment of cervical disc herniations. Acta Neurochir Suppl. 2005;92:79-82.
49. Ogrendik M. Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens. Int J Gen Med. 2013;6:383-386.
50. Rhee DK, Marcelino J, Baker M, et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest. 2005;115:622-631.
51. Cassim B, Shaw OM, Mazur M, et al. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis. Rheumatology (Oxford). 2009;48:490-496.
52. Ma MH, Kingsley GH, Scott DL. A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2010;49:91-98.
53. Cho HY, Morgan DL, Bauer AK, Kleeberger SR. Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice. Am J Respir Crit Care Med. 2007;175:829-839.
54. Fakhrzadeh L, Laskin JD, Laskin DL. Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am J Physiol Lung Cell Mol Physiol. 2004;287:L279-285.
55. Chen H, Yu B, Lu C, Lin Q. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-alpha, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Rheumatol Int. 2013;33:1223-1227.
56. Hasan O, Jessar M, Ashar M, Noordin S, Ahmad T. Systemic sclerosis: Clinical manifestations, anesthetic and orthopedic considerations in a patient. Int J Surg Case Rep. 2018;42:24-28.
57. Nowicka D. Thermography improves clinical assessment in patients with systemic sclerosis treated with ozone therapy. BioMed Research International. 2017;2017:7.
58. Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol. 1999;11:119-126.
59. Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal. 2006;8:243-270.
60. Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646-682.
61. Bocci V. Ozone: A New Medical Drug. Dordrecht, The Netherlands: Springer. 2005.
62. Bocci V. Oxygen-Ozone Therapy: A Critical Evaluation. Springer Science & Business Media. 2013.
63. Vélez BPL. Ozone therapy, a supplement for patients with fibromyalgia. Revista Española de Ozonoterapia. 2014;4:39-49.
64. Clavo B, Perez JL, Lopez L, et al. Effect of ozone therapy on muscle oxygenation. J Altern Complement Med. 2003;9:251-256.
65. Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2001;80:745-748.
66. Ballardini E. Oxygen-ozone therapy for spinal muscle disorders in the horse. Vol 42005.
67. Bhatt J, Bhat A, Dhama K, Amarpal A. An overview of ozone therapy in equine: an emerging healthcare solution. J Exp Biol Agric Sci. 2016;4:S203-210.
68. Freburger JK, Holmes GM, Agans RP, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169:251-258.
69. Alexandre A, Buric J, Paradiso R. Intradiscal injection of O2-O3 to treat lumbar disc herniations: Results at five years. Rivista Italiana di Ossigeno-Ozonoterapia. 2002;1:165-169.
70. Ueno I, Hoshino M, Miura T, Shinriki N. Ozone exposure generates free radicals in the blood samples in vitro. Detection by the ESR spin-trapping technique. Free Radic Res.1998;29:127-135.
71. Borrelli E. Mechanism of action of oxygen ozone therapy in the treatment of disc herniation and low back pain. Acta Neurochir Suppl. 2011;108:123-125.
72. Bocci VPR, Pogni R, Corradeschi F, et al. Oxygen-ozone in orthopaedics: EPR detection of hydroxyl free radicals in ozone-treated “nucleus pulposus” material. Neuroradiol J. doi:10.1177/197140090101400106.
73. Torri G, Grazia AD, Casadei C. Clinical experience in the treatment of lumbar disk disease, with a cycle of lumbar muscle injection of an oxygen + ozone mixture. http://www.biaccabi.com/ edocs/um_torri.html. Accessed at 2018-09-03.
74. Magalhaes FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET.Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012;15:E115-129.
75. Lee SY, Kim TH, Oh JK, Lee SJ, Park MS. Lumbar stenosis: a recent update by review of literature. Asian Spine J. 2015;9:818-828.
76. Baeza-Noci J. Spinal ozone therapy in lumbar spinal stenosis. Int J Ozone Ther. 2007;6:17-24.
77. Rosenberg SK, Grabinsky A, Kooser C, Boswell MV.Effectiveness of transforaminal epidural steroid injections in low back pain: a one year experience. Pain Physician. 2002;5:266-270.
78. Abdi S, Datta S, F Lucas L. Role of epidural steroids in the management of chronic spinal pain: a systematic review of effectiveness and complications. Pain Physician. 2005;8:127-143.
79. Bocci V, Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. Haematologica. 1990;75:510-515.
80. Di Filippo C, Cervone C, Rossi C, et al. Antiarrhythmic effect of acute oxygen-ozone administration to rats. Eur J Pharmacol. 2010;629:89-95.
81. Pryor WA, Squadrito GL, Friedman M. A new mechanism for the toxicity of ozone. Toxicol Lett. 1995;82:287-293.
82. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995;19:935-941.
83. Mustafa MG. Biochemical basis of ozone toxicity. Free Radic Biol Med. 1990;9:245-265. Received: 2018-05-30 Accepted: 2018-08-09 C-Editor: Yang LJ, Zhao M; S-Editor: Yu J; L-Editor: Wang L
84. Baeza-Noci, José. “Spinal Ozone Therapy in Lumbar Spinal Stenosis.” (2007).
Peri-Neural Injection Therapy references
Beco J, Mouchel J. Perineural dextrose injections in the treatment of lower urinary tract symptoms and dyspareunia induced by obturator neuralgia. Med Hypotheses. 2020 Nov;144:109991. doi: 10.1016/j.mehy.2020.109991. Epub 2020 Jun 11. PMID: 32570164.
Chen LC, Ho TY, Shen YP, Su YC, Li TY, Tsai CK, Wu YT. Perineural Dextrose and Corticosteroid Injections for Ulnar Neuropathy at the Elbow: A Randomized Double-blind Trial. Arch Phys Med Rehabil. 2020 Aug;101(8):1296-1303. doi: 10.1016/j.apmr.2020.03.016. Epub 2020 Apr 20. PMID: 32325164.
Li TY, Chen SR, Shen YP, Chang CY, Su YC, Chen LC, Wu YT. Long-term outcome after perineural injection with 5% dextrose for carpal tunnel syndrome: a retrospective follow-up study. Rheumatology (Oxford). 2021 Feb 1;60(2):881-887. doi: 10.1093/rheumatology/keaa361. PMID: 32856082.
Wu YT, Wu CH, Lin JA, Su DC, Hung CY, Lam SKH. Efficacy of 5% Dextrose Water Injection for Peripheral Entrapment Neuropathy: A Narrative Review. Int J Mol Sci. 2021 Nov 16;22(22):12358. doi: 10.3390/ijms222212358. PMID: 34830240; PMCID: PMC8621462.
Wu YT, Chen YP, Lam KHS, Reeves KD, Lin JA, Kuo CY. Mechanism of Glucose Water as a Neural Injection: A Perspective on Neuroinflammation. Life (Basel). 2022 Jun 2;12(6):832. doi: 10.3390/life12060832. PMID: 35743863; PMCID: PMC9225069.
Hyaluronic Acid References:
Altman R, Hackel J, Niazi F, Shaw P, Nicholls M. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review. Semin Arthritis Rheum. 2018 Oct;48(2):168-175. doi: 10.1016/j.semarthrit.2018.01.009. Epub 2018 Jan 31. PMID: 29496227.
Belk JW, Houck DA, Littlefield CP, Kraeutler MJ, Potyk AG, Mei-Dan O, Dragoo JL, Frank RM, McCarty EC. Platelet-Rich Plasma Versus Hyaluronic Acid for Hip Osteoarthritis Yields Similarly Beneficial Short-Term Clinical Outcomes: A Systematic Review and Meta-analysis of Level I and II Randomized Controlled Trials. Arthroscopy. 2022 Jun;38(6):2035-2046. doi: 10.1016/j.arthro.2021.11.005. Epub 2021 Nov 14. PMID: 34785294.
Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2021 Jan;49(1):249-260. doi: 10.1177/0363546520909397. Epub 2020 Apr 17. PMID: 32302218.
Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A, Kon E, Filardo G. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial. Am J Sports Med. 2019 Feb;47(2):347-354. doi: 10.1177/0363546518814532. Epub 2018 Dec 13. PMID: 30545242.
Gilat R, Haunschild ED, Knapik DM, Evuarherhe A Jr, Parvaresh KC, Cole BJ. Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis. Int Orthop. 2021 Feb;45(2):345-354. doi: 10.1007/s00264-020-04801-9. Epub 2020 Sep 15. PMID: 32935198.
Raeissadat SA, Ghazi Hosseini P, Bahrami MH, Salman Roghani R, Fathi M, Gharooee Ahangar A, Darvish M. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021 Feb 3;22(1):134. doi: 10.1186/s12891-021-04017-x. PMID: 33536010; PMCID: PMC7860007.
Tang JZ, Nie MJ, Zhao JZ, Zhang GC, Zhang Q, Wang B. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis. J Orthop Surg Res. 2020 Sep 11;15(1):403. doi: 10.1186/s13018-020-01919-9. PMID: 32912243; PMCID: PMC7488405.